Pentair_Endocsope reprocessor

of 10
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
    September 2010 CONFIDENTIAL This report is solely for the use of client personnel. No part of it may be circulated, quoted, or reproduced for distribution outside the client organization without prior written approval from Pipal Research Corporation. Overview of the U.S. Medical Devices Market    Source: Global Data; news articles; Pipal Research analysis 1 Global market size by region U.S. Electrophysiology Mapping and Ablation Market, 2000-2008 Market Value (100%=$ million)  xxx Key Insights Total= 535.9 569.3 605.8 644.1 683.3 721.8 767.7 822.0 899.0 1,855.6 Note: Navigation mapping devices are used in Electrophysiology Mapping and Ablation procedures  A.Market size  –  global and include regional split if possible  –  this should be of the underlying medical device market - if possible and available we should look at the filtration used in these medical device markets B.In the insights, we can capture key trends  Intensifying Completion  The U.S. Electrophysiology (EP) Mapping and Ablation Market has been witnessing rise in competition, primarily owing to players’ focus upon developing propriety technologies and the increasing consolidation of the market Growth via Technological Innovation  Players strive to build upon their innovative product portfolio by collaborating with other Electrophysiology and Ablation mapping vendors and launching enhanced capabilities  – Players offering catheter  ‐ based techniques have focused upon making improvements in real ‐ time visualization techniques in fluoroscopy, employing mapping of the electrical signals in the heart or ultrasound in order to visualize the anatomic movements of the heart’s chambers and walls  In future, players offering robust catheter  ‐ based ablation technologies are expected to lead the landscape driven by increasing demand for treatment of Atrial Fibrillation Merger & Acquisitions  Since 2008, various significant acquisitions were carried out in the U.S. Electrophysiology Mapping and Ablation Market  – Medtronic acquired Ablation Frontiers and Cryocath Technologies in February 2009 and December 2008, respectively  –  In 2008, St. Jude Medical acquired EP MedSystems, Inc while Boston Scientific acquired Cryocor, Inc.  The increasing number of acquisitions in the Electrophysiology Mapping and Ablation Market is a strong indication of the fact that companies are targeting the inorganic approach as a key growth strategy Strategic Alliances  Prominent players in the market have been entering into strategic alliances in order to leverage technological innovations  – Companies such as Biosense Webster, Siemens, Philips, Hansen, St. Jude Medical and other cath lab technology providers continue to establish technological alliances among themselves ã In August 2010, St. Jude Medical signed an agreement with Hansen Medical to co-market its EnSite Velocity Cardiac Mapping System with Hansen’s Sensei X CoHesion 3 -D visualization module Key Insights Competitive Structure of the U.S. Electrophysiology Mapping and Ablation Market 2 U.S. Electrophysiology (EP) market is dominated by few players and is expected to be strongly driven by EP and Ablation mapping procedures in the future     Company Total Revenues ($ million, 2009)  AtriCure 54.5 Biosense Webster NA Boston Scientific 8,188.0 Brain Lab NA C. R. Bard 2,534.9 GE Healthcare NA Hansen Medical 22.2 Integra Radionics** 682.5 Medtronic*** 15,817.0 Omega Medical Imaging NA Philips Healthcare NA Siemens Healthcare NA Stereotaxis 51.1 St. Jude Medical 4,681.3 Toshiba Medical Systems NA Key Players* in the U.S. Electrophysiology Mapping and Ablation Market *This is an indicative list **As of March, 2010 ***As of April 30, 2010 Source: Company website; Hoover’s; news articles; Pipal Research analysis     A.Also take geographical info from Cantel AR abount expansion in geographies of ER and steris ap is available  3  The Company is a manufacturer of cardiosurgery, hemodialysis, and water purification equipment as well as medical reprocessing units and sterilants.  – Cardiosurgery products include hemofilters and hemoconcentrators, while hemodialysis products include dialyzers and concentrates  – The Company also offer advance endoscope reprocessor, cleaners, automated endoscope reprocessor (AER) and other other equipments  Automated Endoscope Reprocessor products of the Company includes:  – DSD Edge AER : It is a dual-basin, asynchronous automated endoscope reprocessor, designed for use in hospitals and surgery centers. The DSD Edge provides a quick endoscope turn-around time with a reprocessing cycle of 22 minutes. In Apl 2010 this product received FDA clearance  – DSD-201 AER: This product includes features such as a faster cycle times, dual basin, automated self-disinfection, automatic log print at cycle end, continuous cycle and batch counts, self-priming HLD (high level disinfected) pumps, and HLD temperature monitoring and display . Enhanced s ystem options are also available which includes automated endoscope leak testing, vapour management systems, and lid locks for added operator safety  – SSD-102 AER: This product is a single basin version automated endoscope reprocessor, and incorporates all the features available on the dual basin DSD-201.  – CER-1 and CER-2 Countertop Semi-Automated Endoscope Reprocessor: The equipment encompass a compact design with single or dual endoscope reprocessing capability, two-stage water pre-filtration etc  – Advantage AER:  A computer based endoscope reprocessors which features dual asynchronous basins, simple touchpad control, and large flat-screen displays along with a barcode reader and hands-free lid operation   Product/Service Offerings ote: * Endoscope Reprocessor segment; ource:Company website; news articles; Pipal Research analysis Minntech Corporation    Established in year 1974, Minntech Corporation, a Minneapolis, Minnesota based company is engaged in developing, manufacturing, and marketing medical devices, sterilants, and water purification products  – The Company merged with Cantel Medical Corp in Sep 01, and currently operates as a subsidiary of Cantel Medical Corp  The Company itself operates through four subsidiaries and business units viz; Renal Systems Group, Minntech Therapeutic Technologies, Medivators Reprocessing Systems (MRS) and Minntech International  – The Renal Systems business units, is a producer of dialyzer reprocessing systems and hemodialysis concentrates, while the Medivators business unit is involved in developing, manufacturing, and marketing of comprehensive range of endoscope reprocessing equipments, chemicals and accessories.  The Company sells its products primarily to hospitals, clinics, and kidney treatment centers through network of independent distribution partners globally  – In U.S., Medivators has team of 24 sales representatives, 21 field service engineers and 9 clinical support specialists. In addition to those teams, Medivators employs an extensive in-house support group using highly-trained technical and customer service personnel  Minntech has its facilities spread across globally In countries such as the U.S, the Netherlands, Singapore, China and Japan  –  All manufacturing facilities have received certification to ISO 13485/2003 and products are manufactured under quality standards including ISO 13485 and FDA’s quality system regulations   Key Financials and Other Data* Background Headquarters/Ownership 65.5 million 7.5 million NA 36.2 million NA Revenue: Operating Income: Net Income: Total Assets: Employees: Market Capitalization: Ownership:  Address: City, State: Telephone: Website: Product Manager : vvvv Subsidiary 14605 28th Avenue North Minneapolis MN 55447, U.S. 800-444-4729
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks